Kirk Johnson, PhD

Chief Scientific Officer
AmMax Biopharma
Redwood City, California, United States

Presentation(s):

• Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR

  Friday, November 18, 2022
  11:29 AM – 11:37 AM